Studies have shown that AFP-positive HCC patients have a higher proportion of poorly differentiated tumors and vascular invasion compared to AFP-negative patients, which inevitably leads to a poorer prognosis for AFP-positive patients (17). This evidence concerns the gene AFP and hepatocellular carcinoma.